This Month in Psychopharmacology

Pharmacological Treatments for Psychotic Depression

Current treatment guidelines for psychotic depression recommend a c...

Read More

CDC Issues New Guidance on Identifying, Responding to Suicide Clusters

Responding to suicide clusters requires a comprehensive and proacti...

Read More

ADHD Pharmacotherapy and Mortality in Individuals With ADHD

A recent study explored whether initiation of ADHD pharmacotherapy ...

Read More

Caffeine Consumption and Anxiety

Anxiety disorders affect approximately 264 million individuals worl...

Read More

High Sugar Intake Tied to Increased Risk for Depression

A new cross-sectional study examined the association between dietar...

Read More

Science Update: Omega-3 Supplements May Reduce Schizotypal Personality Symptoms

A recent randomized controlled trial examined whether omega-3 fatty...

Read More

Clozapine for Aggression and Violence

A recent post-hoc analysis suggest that cariprazine is a viable tre...

Read More

Erectile Dysfunction Drugs May Protect Against Alzheimer’s

With Alzheimer’s disease (AD) cases projected to reach 157 million ...

Read More

Long-Acting Injectable Versus Oral Antipsychotics in Preventing Psychiatric Rehospitalizations

Individuals with schizophrenia often struggle with consistently tak...

Read More

Efficacy of Cariprazine in Patients with Bipolar Depression and Comorbid Anxiety

A recent post-hoc analysis suggest that cariprazine is a viable tre...

Read More

CBT Helps Hyperactive Brain Circuits In Pediatric Patients With Anxiety Disorders

A new study reveals that cognitive behavioral therapy (CBT) normali...

Read More

Bipolar Disorder and Cumulative Trauma

A recent review underscores the high prevalence and adverse impacts...

Read More